BioCryst Pharmaceuticals, Inc. (BCRX)

6.65 -0.02 (-0.30%) USD  |  NASDAQ  |  Jan 21, 14:35
More

BioCryst Pharmaceuticals Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Astria Therapeutics, Inc. Upgrade
Hologic, Inc. Upgrade
Bruker Corp. Upgrade
Viatris, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade